Stocktoria

Banca Mediolanum S.p.A. BMED.MI

IT · Borsa Italiana · XMIL · stock · Financial Services · website

Banca Mediolanum S.p.A. (BMED.MI) earns a Piotroski F-score of 4/9 (mixed financial health). It pays a dividend yielding 5.65% (safety: stretched). FY2025 revenue was $2.4B at a 50.7% net margin.

4/9
Piotroski F — financial health
Altman Z″ — distress risk
73.4%
Dividend payout · stretched
$21.78 as of 2026-06-01 · +49% 1y
$14.62$21.7852-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap€16.1B
P / E13×
Net margin50.7%
Revenue trend · last 4y · up

How it ranks in Financial Services · percentile among 50 companies

Piotroski Fstronger than 22%
Net marginstronger than 92%
Return on equitystronger than 92%
Revenue growthstronger than 30%

Percentile vs other Financial Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

FAQ

Is BMED.MI financially healthy?

Banca Mediolanum S.p.A.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).

Does BMED.MI pay a dividend, and is it safe?

Yes. Banca Mediolanum S.p.A. pays a dividend yielding about 5.65% with a 73.4% payout ratio, rated “stretched” for safety.

How profitable is BMED.MI?

In FY2025, Banca Mediolanum S.p.A. had a net margin of 50.7% and a return on equity of 27.5%.

Source: company filings via Yahoo Finance · IT · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.